It was brought to my attention by three students in my clinical group that Andrea was taking medication while at lunch in the cafeteria. As they described she was, \"popping pills\". They stated that she \"could not keep her head up\" and appeared visibly dazed. Naturally, I became concerned for both her and the patient she was assigned to. I proceeded to the sixth floor to speak to Mr. Kaslavage, her clinical instructor, but he was at lunch at the time. As I was waited on the unit Andrea returned to the floor. I approached Andrea and said her name three times before she realized or acknowledged I was speaking to her. She appeared dis-shoveled and confused. Her eyes were glossy in appearance. I told her I would like to speak to her in private along with Mrs. Olenginski. She began to become increasing nervous. I told her to relax and that I wanted to talk to her in private. We proceeded to the fourth floor where both Mrs. Olenginski & I questioned her about the incident. I informed her that her behavior was suspicious and that she appeared to be slow to respond to questions and her eyes where glossy. She stated she has anxiety and has a prescription for Xanax to be taken BID. She denied taking the Xanax at clinical. She agreed to take the random drug test based on our suspicions and was escorted to the lab.  